Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine, Adsorbed

CHEBI:CHEBI_751801

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

listing_expiration_date
20241231
route
INTRAMUSCULAR
dosage_form
SUSPENSION
product_type
VACCINE
marketing_category
BLA
pharm_class
Pertussis Vaccine [CS]
labeler_name
GlaxoSmithKline Biologicals SA
active_ingredient_name
BORDETELLA PERTUSSIS TOXOID ANTIGEN (FORMALDEHYDE, GLUTARALDEHYDE INACTIVATED)
generic_name
Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine, Adsorbed
brand_name
BOOSTRIX
brand_name_base
BOOSTRIX
product_ndc
58160-842
application_number
BLA125106
marketing_start_date
20090724
package_marketing_start_date
20090724
spl_id
4a2b9df9-db5f-4318-a8bd-d576e7bbb6f0
active_ingredient_strength
2.5 [iU]/.5mL
package_ndc
58160-842-52
package_description
10 SYRINGE in 1 CARTON (58160-842-52) / .5 mL in 1 SYRINGE (58160-842-43)
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class